These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 501942)

  • 1. Fibrinolytic and coagulation systems in the blood vessels in stroke-prone SHR (SHRSP) [proceedings].
    Yamori Y; Ohta K; Horie R; Nara Y; Ohtaka M; Ooshima A
    Jpn Heart J; 1979 Sep; 20(5):698. PubMed ID: 501942
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet function and fibrinolytic system in SHR [proceedings].
    Yamori Y; Ohta K; Nara Y; Ohtaka M; Horie R; Ooshima A
    Jpn Heart J; 1979 Sep; 20(5):747. PubMed ID: 501981
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet Ca2+ is not increased in stroke-prone spontaneously hypertensive rats: comparative study with spontaneously hypertensive rats.
    Ono N; Oshima T; Ishida M; Ishida T; Matsuura H; Kambe M; Kajiyama G
    Hypertension; 1996 Jun; 27(6):1312-7. PubMed ID: 8641741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomembrane characteristics in stroke-prone spontaneously hypertensive rats (SHRSP).
    Yamori Y; Nara Y; Horie R; Ohtaka M; Ohta K; Mitani F
    Jpn Heart J; 1978 Jul; 19(4):597-8. PubMed ID: 731895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high fat-cholesterol (HFC) diet on the microviscosity and phospholipid/cholesterol ratio of erythrocytes in stroke-prone SHR (SHRSP) [proceedings].
    Yamori Y; Ohta K; Horie R; Nara Y; Ohtaka M; Ooshima A
    Jpn Heart J; 1979 Sep; 20(5):750. PubMed ID: 501983
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic study of thrombogenesis on stroke-prone spontaneously hypertensive rats (SHRSP). (1) Thrombopoiesis and platelet consumption in early stage (10 weeks) associated with remarkable increase of blood pressure [proceedings].
    Koganemaru S; Nakagawa J; Okita H; Kuramoto A; Uchino H
    Jpn Heart J; 1977 Jul; 18(4):598-9. PubMed ID: 909196
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and bound forms of atrial natriuretic peptide (ANP) in rat plasma: preferential increase of free ANP in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP).
    Kato J; Kida O; Kita T; Nakamura S; Sasaki A; Kodama K; Tanaka K
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1084-9. PubMed ID: 2968794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen-mediated platelet aggregation in SHR and stroke-prone SHR [proceedings].
    Yamori Y; Ohta K; Horie R; Nara Y
    Jpn Heart J; 1977 Jul; 18(4):596-7. PubMed ID: 909195
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboplastic and fibrinolytic activity of autogenous-free vein grafts used as abdominal aorta replacements in dogs.
    Głowiński S; Worowski K
    Haemostasis; 1980; 9(3):167-74. PubMed ID: 7189500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective calcium transport in platelets from stroke-prone spontaneously hypertensive rats.
    Umegaki K; Ikeda M; Tomita T
    Thromb Res; 1986 Feb; 41(3):415-23. PubMed ID: 3705015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator and thromboplastin activity from sheep alveolar macrophages.
    Wasi S; Burrowes CE; Hay JB; Movat HZ
    Thromb Res; 1983 Apr; 30(1):27-45. PubMed ID: 6683004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation-fibrinolysis abnormalities in poststroke patients.
    Oztürk S; Bruck D; Feinberg WM
    Stroke; 1994 Aug; 25(8):1702-3. PubMed ID: 8042227
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in blood fibrinolysis in occlusive stroke.
    Dube RK; Saha PK; Dube B; Katiyar BC; Rao PV
    Indian J Med Res; 1978 Sep; 68():492-4. PubMed ID: 744637
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution and variation of thromboplastic and fibrinolytic activity of dacron aortic grafts.
    Głowiński S; Worowski K
    Cor Vasa; 1979; 21(4):296-303. PubMed ID: 160300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral plasminogen activator activity in spontaneously hypertensive stroke-prone rats.
    Matsuo O; Okada K; Fukao H; Suzuki A; Ueshima S
    Stroke; 1992 Jul; 23(7):995-9. PubMed ID: 1615551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke.
    Andreotti F; Davies GJ; Hackett DR; Khan MI; De Bart AC; Aber VR; Maseri A; Kluft C
    Am J Cardiol; 1988 Sep; 62(9):635-7. PubMed ID: 3137799
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced thrombogenicity and altered hemodynamics in the cerebral microvasculature of stroke-prone spontaneously hypertensive rats.
    Noguchi T; Sasaki Y; Seki J; Giddings JC; Yamamoto J
    Haemostasis; 1997; 27(5):237-45. PubMed ID: 9690482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.